Keyphrases
Antitumor
16%
Ascites
16%
Ascitic Fluid
16%
Background Current
16%
Beneficial Outcomes
16%
Biodistribution
16%
Cancer Immunotherapy
16%
Cancer Model
16%
Consecutive Days
33%
Days of Treatment
33%
Decorated Nanoparticles
100%
Disease Model
16%
Double Transgenic Mice
16%
FVB Mice
16%
High Response Rate
16%
Immune Parameters
16%
Immunosuppressive Microenvironment
16%
Immunosuppressive Tumor
16%
Large Population
16%
Late-onset
16%
Luciferase Reporter
16%
M1 Macrophage Polarization
16%
M1 Phenotype
16%
Macrophage Repolarization
16%
Macrophages
50%
Mannose
100%
Mouse Model
33%
Nanoparticle Systems
16%
New Therapies
16%
Nuclear factor-κB
50%
Ovarian Cancer
100%
Ovarian Cancer Progression
16%
Ovarian Tumor
16%
Polymeric Nanoparticles
16%
Pro-tumor
16%
Repolarization
16%
Small Interfering RNA (siRNA)
66%
Solid Tumors
33%
Syngeneic
16%
Targeted Tumor
16%
Therapeutic Effect
16%
Therapeutic Efficacy
16%
Translational Potential
16%
Translational Strategies
16%
Tumor
33%
Tumor Burden
33%
Tumor Immunity
100%
Tumor Model
16%
Tumor Phenotype
16%
Tumor-associated Macrophages
100%
Medicine and Dentistry
Ascites
10%
Ascites Fluid
10%
Biodistribution
10%
Cancer Growth
10%
Cancer Immunotherapy
10%
Cancer Model
10%
Cell Composition
10%
Clinical Study
10%
Combination Therapy
10%
Disease Model
10%
Diseases
20%
Immunocompetent Cell
10%
Immunosuppressive Drug
20%
In Vitro
10%
Luciferase
10%
Macrophage
100%
Macrophage Polarization
10%
Mannose
100%
Nanoparticle
100%
Neoplasm
100%
Nuclear Factor
30%
Ovarian Cancer
100%
Ovarian Tumor
10%
Repolarization
20%
Small Interfering RNA
40%
Solid Malignant Neoplasm
20%
Therapy Effect
10%
Transgenic Mouse
10%
Tumor Immunity
100%
Tumor Microenvironment
10%
Tumor Model
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ascites
16%
Biodistribution
8%
Cancer Growth
8%
Cancer Model
8%
Clinical Study
8%
Combination Therapy
8%
Disease Model
8%
Diseases
16%
FVB Mouse
8%
Immunosuppressive Agent
16%
Immunotherapy
8%
Luciferase
8%
Malignant Neoplasm
8%
Mannose
100%
Mouse Model
16%
Nanoparticle
100%
Neoplasm
100%
Nuclear Factor
25%
Ovary Cancer
100%
Ovary Tumor
8%
Small Interfering RNA
33%
Solid Malignant Neoplasm
16%
Therapeutic Effect
8%
Transgenic Mouse
8%
Tumor Microenvironment
8%
Tumor Model
8%
Immunology and Microbiology
Ascites Fluid
20%
Cancer Immunotherapy
20%
Cell Composition
20%
FVB Mouse
20%
Immunocompetent Cell
20%
Immunosuppressive Drug
40%
M1 Macrophage Polarization
20%
Macrophage
100%
Mouse Model
40%
Polymerization
20%
Repolarization
40%
Syngenic
20%
Transgenic Mouse
20%
Tumor Immunity
100%
Tumor Volume
40%
Tumor-Associated Macrophage
100%